nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Nucleoside Analog—Azathioprine—multiple sclerosis	0.586	1	CiPCiCtD
Valaciclovir—SLC15A2—multiple sclerosis	0.341	1	CbGaD
Valaciclovir—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00328	0.279	CbGpPWpGaD
Valaciclovir—Valganciclovir—SLC15A2—multiple sclerosis	0.00191	1	CrCbGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.00101	0.0857	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000593	0.0504	CbGpPWpGaD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000514	0.0437	CbGpPWpGaD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000442	0.0376	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000442	0.0376	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000309	0.0263	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000269	0.0229	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000265	0.0225	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000261	0.0221	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000201	0.0171	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000173	0.0147	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000147	0.0125	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000144	0.0123	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000144	0.0122	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000144	0.0122	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00014	0.0119	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000135	0.0115	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000122	0.0104	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000121	0.0103	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000116	0.0099	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000112	0.00949	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000104	0.0088	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000102	0.00868	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000101	0.00856	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.51e-05	0.00808	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SRM—multiple sclerosis	9.11e-05	0.00774	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.83e-05	0.0075	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.82e-05	0.0075	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	8.64e-05	0.00735	CbGpPWpGaD
Valaciclovir—Dizziness—Azathioprine—multiple sclerosis	8.26e-05	0.00141	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	8.26e-05	0.00141	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—multiple sclerosis	8.22e-05	0.0014	CcSEcCtD
Valaciclovir—Cough—Triamcinolone—multiple sclerosis	8.14e-05	0.00139	CcSEcCtD
Valaciclovir—Convulsion—Triamcinolone—multiple sclerosis	8.09e-05	0.00138	CcSEcCtD
Valaciclovir—Tachycardia—Prednisolone—multiple sclerosis	8.08e-05	0.00138	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—multiple sclerosis	8.07e-05	0.00138	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.07e-05	0.00686	CbGpPWpGaD
Valaciclovir—Convulsion—Methylprednisolone—multiple sclerosis	8.07e-05	0.00138	CcSEcCtD
Valaciclovir—Hypertension—Triamcinolone—multiple sclerosis	8.06e-05	0.00138	CcSEcCtD
Valaciclovir—Hypertension—Methylprednisolone—multiple sclerosis	8.04e-05	0.00137	CcSEcCtD
Valaciclovir—Urticaria—Mitoxantrone—multiple sclerosis	8.02e-05	0.00137	CcSEcCtD
Valaciclovir—Body temperature increased—Mitoxantrone—multiple sclerosis	7.98e-05	0.00136	CcSEcCtD
Valaciclovir—Abdominal pain—Mitoxantrone—multiple sclerosis	7.98e-05	0.00136	CcSEcCtD
Valaciclovir—Myalgia—Triamcinolone—multiple sclerosis	7.95e-05	0.00136	CcSEcCtD
Valaciclovir—Vomiting—Azathioprine—multiple sclerosis	7.94e-05	0.00136	CcSEcCtD
Valaciclovir—Arthralgia—Methylprednisolone—multiple sclerosis	7.93e-05	0.00135	CcSEcCtD
Valaciclovir—Myalgia—Methylprednisolone—multiple sclerosis	7.93e-05	0.00135	CcSEcCtD
Valaciclovir—Rash—Azathioprine—multiple sclerosis	7.88e-05	0.00134	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	7.87e-05	0.00134	CcSEcCtD
Valaciclovir—Dermatitis—Azathioprine—multiple sclerosis	7.87e-05	0.00134	CcSEcCtD
Valaciclovir—Depression—Methotrexate—multiple sclerosis	7.86e-05	0.00134	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.85e-05	0.00667	CbGpPWpGaD
Valaciclovir—Headache—Azathioprine—multiple sclerosis	7.82e-05	0.00134	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.8e-05	0.00663	CbGpPWpGaD
Valaciclovir—Dry mouth—Triamcinolone—multiple sclerosis	7.77e-05	0.00133	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—multiple sclerosis	7.75e-05	0.00132	CcSEcCtD
Valaciclovir—Angioedema—Betamethasone—multiple sclerosis	7.74e-05	0.00132	CcSEcCtD
Valaciclovir—Angioedema—Dexamethasone—multiple sclerosis	7.74e-05	0.00132	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—multiple sclerosis	7.69e-05	0.00131	CcSEcCtD
Valaciclovir—Confusional state—Methylprednisolone—multiple sclerosis	7.66e-05	0.00131	CcSEcCtD
Valaciclovir—Immune system disorder—Prednisone—multiple sclerosis	7.65e-05	0.00131	CcSEcCtD
Valaciclovir—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.62e-05	0.0013	CcSEcCtD
Valaciclovir—Oedema—Triamcinolone—multiple sclerosis	7.62e-05	0.0013	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.6e-05	0.0013	CcSEcCtD
Valaciclovir—Infection—Triamcinolone—multiple sclerosis	7.57e-05	0.00129	CcSEcCtD
Valaciclovir—Infection—Methylprednisolone—multiple sclerosis	7.55e-05	0.00129	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—multiple sclerosis	7.52e-05	0.00128	CcSEcCtD
Valaciclovir—Insomnia—Prednisolone—multiple sclerosis	7.49e-05	0.00128	CcSEcCtD
Valaciclovir—Alopecia—Prednisone—multiple sclerosis	7.49e-05	0.00128	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—multiple sclerosis	7.46e-05	0.00127	CcSEcCtD
Valaciclovir—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.45e-05	0.00127	CcSEcCtD
Valaciclovir—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.44e-05	0.00127	CcSEcCtD
Valaciclovir—Paraesthesia—Prednisolone—multiple sclerosis	7.44e-05	0.00127	CcSEcCtD
Valaciclovir—Tachycardia—Triamcinolone—multiple sclerosis	7.43e-05	0.00127	CcSEcCtD
Valaciclovir—Nausea—Azathioprine—multiple sclerosis	7.42e-05	0.00127	CcSEcCtD
Valaciclovir—Tachycardia—Methylprednisolone—multiple sclerosis	7.42e-05	0.00127	CcSEcCtD
Valaciclovir—Skin disorder—Methylprednisolone—multiple sclerosis	7.38e-05	0.00126	CcSEcCtD
Valaciclovir—Convulsion—Dexamethasone—multiple sclerosis	7.34e-05	0.00125	CcSEcCtD
Valaciclovir—Convulsion—Betamethasone—multiple sclerosis	7.34e-05	0.00125	CcSEcCtD
Valaciclovir—Hypertension—Betamethasone—multiple sclerosis	7.31e-05	0.00125	CcSEcCtD
Valaciclovir—Hypertension—Dexamethasone—multiple sclerosis	7.31e-05	0.00125	CcSEcCtD
Valaciclovir—Asthenia—Mitoxantrone—multiple sclerosis	7.24e-05	0.00124	CcSEcCtD
Valaciclovir—Myalgia—Betamethasone—multiple sclerosis	7.21e-05	0.00123	CcSEcCtD
Valaciclovir—Myalgia—Dexamethasone—multiple sclerosis	7.21e-05	0.00123	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.14e-05	0.00607	CbGpPWpGaD
Valaciclovir—Pain—Prednisolone—multiple sclerosis	7.08e-05	0.00121	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—multiple sclerosis	7.08e-05	0.00121	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—multiple sclerosis	7.03e-05	0.0012	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—multiple sclerosis	6.99e-05	0.00119	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—multiple sclerosis	6.94e-05	0.00119	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.94e-05	0.00119	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.92e-05	0.00118	CcSEcCtD
Valaciclovir—Oedema—Betamethasone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Valaciclovir—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Valaciclovir—Oedema—Dexamethasone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Valaciclovir—Anaphylactic shock—Betamethasone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Valaciclovir—Diarrhoea—Mitoxantrone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Valaciclovir—Insomnia—Triamcinolone—multiple sclerosis	6.89e-05	0.00118	CcSEcCtD
Valaciclovir—Insomnia—Methylprednisolone—multiple sclerosis	6.87e-05	0.00117	CcSEcCtD
Valaciclovir—Infection—Betamethasone—multiple sclerosis	6.87e-05	0.00117	CcSEcCtD
Valaciclovir—Infection—Dexamethasone—multiple sclerosis	6.87e-05	0.00117	CcSEcCtD
Valaciclovir—Paraesthesia—Triamcinolone—multiple sclerosis	6.84e-05	0.00117	CcSEcCtD
Valaciclovir—Feeling abnormal—Prednisolone—multiple sclerosis	6.83e-05	0.00117	CcSEcCtD
Valaciclovir—Paraesthesia—Methylprednisolone—multiple sclerosis	6.83e-05	0.00117	CcSEcCtD
Valaciclovir—Anaemia—Prednisone—multiple sclerosis	6.82e-05	0.00116	CcSEcCtD
Valaciclovir—Dyspnoea—Triamcinolone—multiple sclerosis	6.79e-05	0.00116	CcSEcCtD
Valaciclovir—Nervous system disorder—Betamethasone—multiple sclerosis	6.78e-05	0.00116	CcSEcCtD
Valaciclovir—Nervous system disorder—Dexamethasone—multiple sclerosis	6.78e-05	0.00116	CcSEcCtD
Valaciclovir—Agitation—Prednisone—multiple sclerosis	6.78e-05	0.00116	CcSEcCtD
Valaciclovir—Thrombocytopenia—Betamethasone—multiple sclerosis	6.77e-05	0.00116	CcSEcCtD
Valaciclovir—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.77e-05	0.00116	CcSEcCtD
Valaciclovir—Tachycardia—Dexamethasone—multiple sclerosis	6.75e-05	0.00115	CcSEcCtD
Valaciclovir—Tachycardia—Betamethasone—multiple sclerosis	6.75e-05	0.00115	CcSEcCtD
Valaciclovir—Angioedema—Prednisone—multiple sclerosis	6.74e-05	0.00115	CcSEcCtD
Valaciclovir—Dyspepsia—Triamcinolone—multiple sclerosis	6.71e-05	0.00115	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—multiple sclerosis	6.69e-05	0.00114	CcSEcCtD
Valaciclovir—Dyspepsia—Methylprednisolone—multiple sclerosis	6.69e-05	0.00114	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.64e-05	0.00565	CbGpPWpGaD
Valaciclovir—Anorexia—Betamethasone—multiple sclerosis	6.59e-05	0.00113	CcSEcCtD
Valaciclovir—Anorexia—Dexamethasone—multiple sclerosis	6.59e-05	0.00113	CcSEcCtD
Valaciclovir—Urticaria—Prednisolone—multiple sclerosis	6.58e-05	0.00112	CcSEcCtD
Valaciclovir—Fatigue—Triamcinolone—multiple sclerosis	6.57e-05	0.00112	CcSEcCtD
Valaciclovir—Fatigue—Methylprednisolone—multiple sclerosis	6.55e-05	0.00112	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.55e-05	0.00557	CbGpPWpGaD
Valaciclovir—Pain—Triamcinolone—multiple sclerosis	6.51e-05	0.00111	CcSEcCtD
Valaciclovir—Vomiting—Mitoxantrone—multiple sclerosis	6.42e-05	0.0011	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP24A1—multiple sclerosis	6.42e-05	0.00545	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP27B1—multiple sclerosis	6.42e-05	0.00545	CbGpPWpGaD
Valaciclovir—Immune system disorder—Methotrexate—multiple sclerosis	6.4e-05	0.00109	CcSEcCtD
Valaciclovir—Convulsion—Prednisone—multiple sclerosis	6.39e-05	0.00109	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—multiple sclerosis	6.38e-05	0.00109	CcSEcCtD
Valaciclovir—Hypertension—Prednisone—multiple sclerosis	6.37e-05	0.00109	CcSEcCtD
Valaciclovir—Rash—Mitoxantrone—multiple sclerosis	6.37e-05	0.00109	CcSEcCtD
Valaciclovir—Dermatitis—Mitoxantrone—multiple sclerosis	6.36e-05	0.00109	CcSEcCtD
Valaciclovir—Chills—Methotrexate—multiple sclerosis	6.35e-05	0.00108	CcSEcCtD
Valaciclovir—Headache—Mitoxantrone—multiple sclerosis	6.33e-05	0.00108	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.3e-05	0.00108	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.3e-05	0.00108	CcSEcCtD
Valaciclovir—Myalgia—Prednisone—multiple sclerosis	6.28e-05	0.00107	CcSEcCtD
Valaciclovir—Arthralgia—Prednisone—multiple sclerosis	6.28e-05	0.00107	CcSEcCtD
Valaciclovir—Feeling abnormal—Triamcinolone—multiple sclerosis	6.28e-05	0.00107	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.27e-05	0.00533	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.26e-05	0.00107	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—multiple sclerosis	6.26e-05	0.00107	CcSEcCtD
Valaciclovir—Insomnia—Dexamethasone—multiple sclerosis	6.25e-05	0.00107	CcSEcCtD
Valaciclovir—Insomnia—Betamethasone—multiple sclerosis	6.25e-05	0.00107	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.24e-05	0.00106	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.22e-05	0.00106	CcSEcCtD
Valaciclovir—Paraesthesia—Betamethasone—multiple sclerosis	6.21e-05	0.00106	CcSEcCtD
Valaciclovir—Paraesthesia—Dexamethasone—multiple sclerosis	6.21e-05	0.00106	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.17e-05	0.00524	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Prednisolone—multiple sclerosis	6.1e-05	0.00104	CcSEcCtD
Valaciclovir—Dyspepsia—Betamethasone—multiple sclerosis	6.08e-05	0.00104	CcSEcCtD
Valaciclovir—Dyspepsia—Dexamethasone—multiple sclerosis	6.08e-05	0.00104	CcSEcCtD
Valaciclovir—Urticaria—Triamcinolone—multiple sclerosis	6.05e-05	0.00103	CcSEcCtD
Valaciclovir—Urticaria—Methylprednisolone—multiple sclerosis	6.04e-05	0.00103	CcSEcCtD
Valaciclovir—Body temperature increased—Triamcinolone—multiple sclerosis	6.02e-05	0.00103	CcSEcCtD
Valaciclovir—Anaphylactic shock—Prednisone—multiple sclerosis	6.02e-05	0.00103	CcSEcCtD
Valaciclovir—Oedema—Prednisone—multiple sclerosis	6.02e-05	0.00103	CcSEcCtD
Valaciclovir—Abdominal pain—Methylprednisolone—multiple sclerosis	6.01e-05	0.00103	CcSEcCtD
Valaciclovir—Decreased appetite—Dexamethasone—multiple sclerosis	6.01e-05	0.00103	CcSEcCtD
Valaciclovir—Decreased appetite—Betamethasone—multiple sclerosis	6.01e-05	0.00103	CcSEcCtD
Valaciclovir—Nausea—Mitoxantrone—multiple sclerosis	6e-05	0.00102	CcSEcCtD
Valaciclovir—Infection—Prednisone—multiple sclerosis	5.98e-05	0.00102	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	5.97e-05	0.00102	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	5.97e-05	0.00102	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—multiple sclerosis	5.96e-05	0.00102	CcSEcCtD
Valaciclovir—Fatigue—Dexamethasone—multiple sclerosis	5.96e-05	0.00102	CcSEcCtD
Valaciclovir—Fatigue—Betamethasone—multiple sclerosis	5.96e-05	0.00102	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.92e-05	0.00503	CbGpPWpGaD
Valaciclovir—Pain—Betamethasone—multiple sclerosis	5.91e-05	0.00101	CcSEcCtD
Valaciclovir—Pain—Dexamethasone—multiple sclerosis	5.91e-05	0.00101	CcSEcCtD
Valaciclovir—Nervous system disorder—Prednisone—multiple sclerosis	5.9e-05	0.00101	CcSEcCtD
Valaciclovir—Tachycardia—Prednisone—multiple sclerosis	5.87e-05	0.001	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GPC5—multiple sclerosis	5.87e-05	0.00499	CbGpPWpGaD
Valaciclovir—Skin disorder—Prednisone—multiple sclerosis	5.85e-05	0.000998	CcSEcCtD
Valaciclovir—Anorexia—Prednisone—multiple sclerosis	5.74e-05	0.00098	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—multiple sclerosis	5.7e-05	0.000973	CcSEcCtD
Valaciclovir—Feeling abnormal—Dexamethasone—multiple sclerosis	5.7e-05	0.000973	CcSEcCtD
Valaciclovir—Feeling abnormal—Betamethasone—multiple sclerosis	5.7e-05	0.000973	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.65e-05	0.000965	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.65e-05	0.000965	CcSEcCtD
Valaciclovir—Hypersensitivity—Triamcinolone—multiple sclerosis	5.61e-05	0.000958	CcSEcCtD
Valaciclovir—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.6e-05	0.000956	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—multiple sclerosis	5.52e-05	0.000942	CcSEcCtD
Valaciclovir—Urticaria—Betamethasone—multiple sclerosis	5.49e-05	0.000938	CcSEcCtD
Valaciclovir—Urticaria—Dexamethasone—multiple sclerosis	5.49e-05	0.000938	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.48e-05	0.000936	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.48e-05	0.00466	CbGpPWpGaD
Valaciclovir—Dizziness—Prednisolone—multiple sclerosis	5.48e-05	0.000935	CcSEcCtD
Valaciclovir—Asthenia—Triamcinolone—multiple sclerosis	5.47e-05	0.000933	CcSEcCtD
Valaciclovir—Body temperature increased—Betamethasone—multiple sclerosis	5.46e-05	0.000933	CcSEcCtD
Valaciclovir—Body temperature increased—Dexamethasone—multiple sclerosis	5.46e-05	0.000933	CcSEcCtD
Valaciclovir—Abdominal pain—Betamethasone—multiple sclerosis	5.46e-05	0.000933	CcSEcCtD
Valaciclovir—Abdominal pain—Dexamethasone—multiple sclerosis	5.46e-05	0.000933	CcSEcCtD
Valaciclovir—Asthenia—Methylprednisolone—multiple sclerosis	5.45e-05	0.000931	CcSEcCtD
Valaciclovir—Insomnia—Prednisone—multiple sclerosis	5.44e-05	0.00093	CcSEcCtD
Valaciclovir—Paraesthesia—Prednisone—multiple sclerosis	5.41e-05	0.000923	CcSEcCtD
Valaciclovir—Pruritus—Triamcinolone—multiple sclerosis	5.39e-05	0.00092	CcSEcCtD
Valaciclovir—Cough—Methotrexate—multiple sclerosis	5.38e-05	0.000918	CcSEcCtD
Valaciclovir—Pruritus—Methylprednisolone—multiple sclerosis	5.38e-05	0.000918	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—multiple sclerosis	5.34e-05	0.000912	CcSEcCtD
Valaciclovir—Dyspepsia—Prednisone—multiple sclerosis	5.3e-05	0.000905	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.26e-05	0.00447	CbGpPWpGaD
Valaciclovir—Myalgia—Methotrexate—multiple sclerosis	5.25e-05	0.000896	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—multiple sclerosis	5.25e-05	0.000896	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—multiple sclerosis	5.25e-05	0.000896	CcSEcCtD
Valaciclovir—Decreased appetite—Prednisone—multiple sclerosis	5.23e-05	0.000894	CcSEcCtD
Valaciclovir—Rash—Prednisolone—multiple sclerosis	5.22e-05	0.000892	CcSEcCtD
Valaciclovir—Dermatitis—Prednisolone—multiple sclerosis	5.22e-05	0.000891	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.21e-05	0.00089	CcSEcCtD
Valaciclovir—Diarrhoea—Methylprednisolone—multiple sclerosis	5.2e-05	0.000888	CcSEcCtD
Valaciclovir—Fatigue—Prednisone—multiple sclerosis	5.19e-05	0.000886	CcSEcCtD
Valaciclovir—Headache—Prednisolone—multiple sclerosis	5.19e-05	0.000886	CcSEcCtD
Valaciclovir—Constipation—Prednisone—multiple sclerosis	5.15e-05	0.000879	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—multiple sclerosis	5.07e-05	0.00431	CbGpPWpGaD
Valaciclovir—Confusional state—Methotrexate—multiple sclerosis	5.07e-05	0.000866	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.06e-05	0.0043	CbGpPWpGaD
Valaciclovir—Dizziness—Triamcinolone—multiple sclerosis	5.04e-05	0.00086	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—multiple sclerosis	5.03e-05	0.000859	CcSEcCtD
Valaciclovir—Dizziness—Methylprednisolone—multiple sclerosis	5.03e-05	0.000858	CcSEcCtD
Valaciclovir—Infection—Methotrexate—multiple sclerosis	5e-05	0.000853	CcSEcCtD
Valaciclovir—Feeling abnormal—Prednisone—multiple sclerosis	4.96e-05	0.000847	CcSEcCtD
Valaciclovir—Asthenia—Betamethasone—multiple sclerosis	4.96e-05	0.000847	CcSEcCtD
Valaciclovir—Asthenia—Dexamethasone—multiple sclerosis	4.96e-05	0.000847	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—multiple sclerosis	4.93e-05	0.000842	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—multiple sclerosis	4.93e-05	0.000841	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Prednisone—multiple sclerosis	4.92e-05	0.000841	CcSEcCtD
Valaciclovir—Nausea—Prednisolone—multiple sclerosis	4.92e-05	0.00084	CcSEcCtD
Valaciclovir—Pruritus—Betamethasone—multiple sclerosis	4.89e-05	0.000835	CcSEcCtD
Valaciclovir—Pruritus—Dexamethasone—multiple sclerosis	4.89e-05	0.000835	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—multiple sclerosis	4.89e-05	0.000834	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—RRM1—multiple sclerosis	4.86e-05	0.00413	CbGpPWpGaD
Valaciclovir—Vomiting—Triamcinolone—multiple sclerosis	4.84e-05	0.000827	CcSEcCtD
Valaciclovir—Vomiting—Methylprednisolone—multiple sclerosis	4.83e-05	0.000825	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.83e-05	0.00411	CbGpPWpGaD
Valaciclovir—Rash—Triamcinolone—multiple sclerosis	4.8e-05	0.00082	CcSEcCtD
Valaciclovir—Dermatitis—Triamcinolone—multiple sclerosis	4.8e-05	0.000819	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—multiple sclerosis	4.8e-05	0.000819	CcSEcCtD
Valaciclovir—Rash—Methylprednisolone—multiple sclerosis	4.79e-05	0.000818	CcSEcCtD
Valaciclovir—Dermatitis—Methylprednisolone—multiple sclerosis	4.79e-05	0.000818	CcSEcCtD
Valaciclovir—Urticaria—Prednisone—multiple sclerosis	4.78e-05	0.000817	CcSEcCtD
Valaciclovir—Headache—Triamcinolone—multiple sclerosis	4.77e-05	0.000815	CcSEcCtD
Valaciclovir—Headache—Methylprednisolone—multiple sclerosis	4.76e-05	0.000813	CcSEcCtD
Valaciclovir—Abdominal pain—Prednisone—multiple sclerosis	4.76e-05	0.000813	CcSEcCtD
Valaciclovir—Body temperature increased—Prednisone—multiple sclerosis	4.76e-05	0.000813	CcSEcCtD
Valaciclovir—Diarrhoea—Dexamethasone—multiple sclerosis	4.73e-05	0.000808	CcSEcCtD
Valaciclovir—Diarrhoea—Betamethasone—multiple sclerosis	4.73e-05	0.000808	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.58e-05	0.000783	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.58e-05	0.00389	CbGpPWpGaD
Valaciclovir—Dizziness—Dexamethasone—multiple sclerosis	4.57e-05	0.000781	CcSEcCtD
Valaciclovir—Dizziness—Betamethasone—multiple sclerosis	4.57e-05	0.000781	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—multiple sclerosis	4.55e-05	0.000777	CcSEcCtD
Valaciclovir—Nausea—Triamcinolone—multiple sclerosis	4.52e-05	0.000773	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—multiple sclerosis	4.52e-05	0.000771	CcSEcCtD
Valaciclovir—Nausea—Methylprednisolone—multiple sclerosis	4.51e-05	0.000771	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—multiple sclerosis	4.48e-05	0.000766	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.48e-05	0.00381	CbGpPWpGaD
Valaciclovir—Somnolence—Methotrexate—multiple sclerosis	4.47e-05	0.000764	CcSEcCtD
Valaciclovir—Hypersensitivity—Prednisone—multiple sclerosis	4.43e-05	0.000757	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—multiple sclerosis	4.43e-05	0.000756	CcSEcCtD
Valaciclovir—Vomiting—Dexamethasone—multiple sclerosis	4.39e-05	0.00075	CcSEcCtD
Valaciclovir—Vomiting—Betamethasone—multiple sclerosis	4.39e-05	0.00075	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.39e-05	0.00373	CbGpPWpGaD
Valaciclovir—Decreased appetite—Methotrexate—multiple sclerosis	4.37e-05	0.000747	CcSEcCtD
Valaciclovir—Rash—Dexamethasone—multiple sclerosis	4.36e-05	0.000744	CcSEcCtD
Valaciclovir—Rash—Betamethasone—multiple sclerosis	4.36e-05	0.000744	CcSEcCtD
Valaciclovir—Dermatitis—Dexamethasone—multiple sclerosis	4.35e-05	0.000744	CcSEcCtD
Valaciclovir—Dermatitis—Betamethasone—multiple sclerosis	4.35e-05	0.000744	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.34e-05	0.000742	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—multiple sclerosis	4.34e-05	0.000741	CcSEcCtD
Valaciclovir—Headache—Dexamethasone—multiple sclerosis	4.33e-05	0.000739	CcSEcCtD
Valaciclovir—Headache—Betamethasone—multiple sclerosis	4.33e-05	0.000739	CcSEcCtD
Valaciclovir—Asthenia—Prednisone—multiple sclerosis	4.32e-05	0.000737	CcSEcCtD
Valaciclovir—Pain—Methotrexate—multiple sclerosis	4.3e-05	0.000735	CcSEcCtD
Valaciclovir—Pruritus—Prednisone—multiple sclerosis	4.26e-05	0.000727	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—multiple sclerosis	4.15e-05	0.000708	CcSEcCtD
Valaciclovir—Diarrhoea—Prednisone—multiple sclerosis	4.12e-05	0.000703	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.11e-05	0.000702	CcSEcCtD
Valaciclovir—Nausea—Dexamethasone—multiple sclerosis	4.11e-05	0.000701	CcSEcCtD
Valaciclovir—Nausea—Betamethasone—multiple sclerosis	4.11e-05	0.000701	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—multiple sclerosis	4e-05	0.000682	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.99e-05	0.00339	CbGpPWpGaD
Valaciclovir—Dizziness—Prednisone—multiple sclerosis	3.98e-05	0.00068	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—multiple sclerosis	3.98e-05	0.000679	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—multiple sclerosis	3.98e-05	0.000679	CcSEcCtD
Valaciclovir—Vomiting—Prednisone—multiple sclerosis	3.83e-05	0.000654	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.82e-05	0.00325	CbGpPWpGaD
Valaciclovir—Rash—Prednisone—multiple sclerosis	3.8e-05	0.000648	CcSEcCtD
Valaciclovir—Dermatitis—Prednisone—multiple sclerosis	3.79e-05	0.000648	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.77e-05	0.00321	CbGpPWpGaD
Valaciclovir—Headache—Prednisone—multiple sclerosis	3.77e-05	0.000644	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—multiple sclerosis	3.71e-05	0.000633	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—multiple sclerosis	3.61e-05	0.000616	CcSEcCtD
Valaciclovir—Nausea—Prednisone—multiple sclerosis	3.58e-05	0.000611	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—multiple sclerosis	3.56e-05	0.000608	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.54e-05	0.00301	CbGpPWpGaD
Valaciclovir—Diarrhoea—Methotrexate—multiple sclerosis	3.44e-05	0.000588	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.38e-05	0.00287	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.33e-05	0.00283	CbGpPWpGaD
Valaciclovir—Dizziness—Methotrexate—multiple sclerosis	3.33e-05	0.000568	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.24e-05	0.00275	CbGpPWpGaD
Valaciclovir—Vomiting—Methotrexate—multiple sclerosis	3.2e-05	0.000546	CcSEcCtD
Valaciclovir—Rash—Methotrexate—multiple sclerosis	3.17e-05	0.000542	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—multiple sclerosis	3.17e-05	0.000541	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.15e-05	0.00268	CbGpPWpGaD
Valaciclovir—Headache—Methotrexate—multiple sclerosis	3.15e-05	0.000538	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.13e-05	0.00266	CbGpPWpGaD
Valaciclovir—Nausea—Methotrexate—multiple sclerosis	2.99e-05	0.00051	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.95e-05	0.00251	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.81e-05	0.00239	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.00237	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.79e-05	0.00237	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.63e-05	0.00224	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.57e-05	0.00218	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.39e-05	0.00203	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.33e-05	0.00198	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.22e-05	0.00189	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.97e-05	0.00168	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOE—multiple sclerosis	1.68e-05	0.00143	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.65e-05	0.0014	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—POMC—multiple sclerosis	1.44e-05	0.00123	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—multiple sclerosis	1.32e-05	0.00112	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.22e-05	0.00103	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.13e-05	0.000959	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1e-05	0.000853	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.37e-06	0.000712	CbGpPWpGaD
